Effects  ||| S:0 E:8 ||| NNS
of  ||| S:8 E:11 ||| IN
Polypropylene  ||| S:11 E:25 ||| NNP
Carbonate ||| S:25 E:34 ||| NNP
/ ||| S:34 E:35 ||| NNP
Poly ||| S:35 E:39 ||| NNP
( ||| S:39 E:40 ||| -LRB-
D ||| S:40 E:41 ||| NNP
, ||| S:41 E:42 ||| ,
L-lactic ||| S:42 E:50 ||| NNP
)  ||| S:50 E:52 ||| -RRB-
Acid ||| S:52 E:56 ||| NNP
/ ||| S:56 E:57 ||| NNP
Tricalcium  ||| S:57 E:68 ||| NNP
Phosphate  ||| S:68 E:78 ||| NNP
Elastic  ||| S:78 E:86 ||| NNP
Composites  ||| S:86 E:97 ||| NNP
on  ||| S:97 E:100 ||| IN
Improving  ||| S:100 E:110 ||| NNP
Osteoblast  ||| S:110 E:121 ||| NNP
Maturation  ||| S:121 E:132 ||| NNP
Bone  ||| S:132 E:137 ||| NNP
tissue  ||| S:137 E:144 ||| NN
engineering  ||| S:144 E:156 ||| NN
utilizing  ||| S:156 E:166 ||| VBZ
biomaterials  ||| S:166 E:179 ||| VBN
to  ||| S:179 E:182 ||| TO
improve  ||| S:182 E:190 ||| VB
osteoblast  ||| S:190 E:201 ||| JJ
growth  ||| S:201 E:208 ||| NN
has  ||| S:208 E:212 ||| VBZ
provided  ||| S:212 E:221 ||| VBN
de  ||| S:221 E:224 ||| IN
novo  ||| S:224 E:229 ||| JJ
consideration  ||| S:229 E:243 ||| NN
for  ||| S:243 E:247 ||| IN
therapy  ||| S:247 E:255 ||| NN
of  ||| S:255 E:258 ||| IN
bone  ||| S:258 E:263 ||| NN
diseases ||| S:263 E:271 ||| NNS
.  ||| S:271 E:273 ||| .
Polypropylene  ||| S:273 E:287 ||| NN
carbonate  ||| S:287 E:297 ||| NNS
( ||| S:297 E:298 ||| -LRB-
PPC ||| S:298 E:301 ||| NNP
)  ||| S:301 E:303 ||| -RRB-
is  ||| S:303 E:306 ||| VBZ
a  ||| S:306 E:308 ||| DT
polymer  ||| S:308 E:316 ||| NN
with  ||| S:316 E:321 ||| IN
a  ||| S:321 E:323 ||| DT
low  ||| S:323 E:327 ||| JJ
glass  ||| S:327 E:333 ||| NN
transition  ||| S:333 E:344 ||| NN
temperature  ||| S:344 E:356 ||| NN
but  ||| S:356 E:360 ||| CC
high  ||| S:360 E:365 ||| JJ
elasticity ||| S:365 E:375 ||| NN
.  ||| S:375 E:377 ||| .
In  ||| S:377 E:380 ||| IN
this  ||| S:380 E:385 ||| DT
study ||| S:385 E:390 ||| NN
,  ||| S:390 E:392 ||| ,
we  ||| S:392 E:395 ||| PRP
developed  ||| S:395 E:405 ||| VBD
a  ||| S:405 E:407 ||| DT
new  ||| S:407 E:411 ||| JJ
PPC-derived  ||| S:411 E:423 ||| JJ
composite  ||| S:423 E:433 ||| NN
by  ||| S:433 E:436 ||| IN
mixing  ||| S:436 E:443 ||| VBG
poly-lactic  ||| S:443 E:455 ||| JJ
acid  ||| S:455 E:460 ||| NN
( ||| S:460 E:461 ||| -LRB-
PLA ||| S:461 E:464 ||| NNP
)  ||| S:464 E:466 ||| -RRB-
and  ||| S:466 E:470 ||| CC
tricalcium  ||| S:470 E:481 ||| JJ
phosphate  ||| S:481 E:491 ||| NNS
( ||| S:491 E:492 ||| -LRB-
TCP ||| S:492 E:495 ||| NNP
) ||| S:495 E:496 ||| -RRB-
,  ||| S:496 E:498 ||| ,
called  ||| S:498 E:505 ||| VBD
PPC ||| S:505 E:508 ||| NNP
/ ||| S:508 E:509 ||| NNP
PLA ||| S:509 E:512 ||| NNP
/ ||| S:512 E:513 ||| NNP
TCP  ||| S:513 E:517 ||| NNP
elastic  ||| S:517 E:525 ||| NNS
( ||| S:525 E:526 ||| -LRB-
PPTE ||| S:526 E:530 ||| NNP
)  ||| S:530 E:532 ||| -RRB-
scaffolds ||| S:532 E:541 ||| NN
.  ||| S:541 E:543 ||| .
We  ||| S:543 E:546 ||| PRP
also  ||| S:546 E:551 ||| RB
evaluated  ||| S:551 E:561 ||| VBN
the  ||| S:561 E:565 ||| DT
beneficial  ||| S:565 E:576 ||| JJ
effects  ||| S:576 E:584 ||| NNS
of  ||| S:584 E:587 ||| IN
PPTE  ||| S:587 E:592 ||| NNP
composites  ||| S:592 E:603 ||| NNS
on  ||| S:603 E:606 ||| IN
osteoblast  ||| S:606 E:617 ||| JJ
growth  ||| S:617 E:624 ||| NN
and  ||| S:624 E:628 ||| CC
maturation  ||| S:628 E:639 ||| NNS
and  ||| S:639 E:643 ||| CC
the  ||| S:643 E:647 ||| DT
possible  ||| S:647 E:656 ||| JJ
mechanisms ||| S:656 E:666 ||| NNS
.  ||| S:666 E:668 ||| .
Compared  ||| S:668 E:677 ||| VBN
to  ||| S:677 E:680 ||| TO
PPC  ||| S:680 E:684 ||| NNP
polymers ||| S:684 E:692 ||| NNS
,  ||| S:692 E:694 ||| ,
PPTE  ||| S:694 E:699 ||| NNP
composites  ||| S:699 E:710 ||| NNS
had  ||| S:710 E:714 ||| VBD
similar  ||| S:714 E:722 ||| JJ
pore  ||| S:722 E:727 ||| JJ
sizes  ||| S:727 E:733 ||| NNS
and  ||| S:733 E:737 ||| CC
porosities  ||| S:737 E:748 ||| NNS
but  ||| S:748 E:752 ||| CC
possessed  ||| S:752 E:762 ||| VBD
better  ||| S:762 E:769 ||| RBR
hydrophilic  ||| S:769 E:781 ||| JJ
surface  ||| S:781 E:789 ||| NN
structures ||| S:789 E:799 ||| NNS
.  ||| S:799 E:801 ||| .
Biological  ||| S:801 E:812 ||| JJ
evaluations  ||| S:812 E:824 ||| NNS
further  ||| S:824 E:832 ||| RB
revealed  ||| S:832 E:841 ||| VBN
that  ||| S:841 E:846 ||| IN
PPTE  ||| S:846 E:851 ||| NNP
composites  ||| S:851 E:862 ||| NNS
attracted  ||| S:862 E:872 ||| VBD
adhesion  ||| S:872 E:881 ||| VBN
of  ||| S:881 E:884 ||| IN
mouse  ||| S:884 E:890 ||| NN
osteoblasts ||| S:890 E:901 ||| NN
,  ||| S:901 E:903 ||| ,
and  ||| S:903 E:907 ||| CC
these  ||| S:907 E:913 ||| DT
bone  ||| S:913 E:918 ||| NN
cells  ||| S:918 E:924 ||| NNS
extended  ||| S:924 E:933 ||| VBN
along  ||| S:933 E:939 ||| IN
the  ||| S:939 E:943 ||| DT
porous  ||| S:943 E:950 ||| JJ
scaffolds  ||| S:950 E:960 ||| NN
to  ||| S:960 E:963 ||| TO
produce  ||| S:963 E:971 ||| VB
accurate  ||| S:971 E:980 ||| JJ
fibroblast-like  ||| S:980 E:996 ||| JJ
morphologies ||| S:996 E:1008 ||| NN
.  ||| S:1008 E:1010 ||| .
In  ||| S:1010 E:1013 ||| IN
parallel ||| S:1013 E:1021 ||| NN
,  ||| S:1021 E:1023 ||| ,
seeding  ||| S:1023 E:1031 ||| FW
mouse  ||| S:1031 E:1037 ||| FW
osteoblasts  ||| S:1037 E:1049 ||| FW
onto  ||| S:1049 E:1054 ||| FW
PPTE  ||| S:1054 E:1059 ||| FW
composites  ||| S:1059 E:1070 ||| FW
time-dependently  ||| S:1070 E:1087 ||| FW
increased  ||| S:1087 E:1097 ||| JJ
cell  ||| S:1097 E:1102 ||| NN
growth ||| S:1102 E:1108 ||| NN
.  ||| S:1108 E:1110 ||| .
Sequentially ||| S:1110 E:1122 ||| NNP
,  ||| S:1122 E:1124 ||| ,
PPTE  ||| S:1124 E:1129 ||| FW
composites  ||| S:1129 E:1140 ||| FW
augmented  ||| S:1140 E:1150 ||| FW
DNA  ||| S:1150 E:1154 ||| NNP
replication  ||| S:1154 E:1166 ||| NN
and  ||| S:1166 E:1170 ||| CC
cell  ||| S:1170 E:1175 ||| NN
proliferation ||| S:1175 E:1188 ||| NN
.  ||| S:1188 E:1190 ||| .
Consequently ||| S:1190 E:1202 ||| RB
,  ||| S:1202 E:1204 ||| ,
PPTE  ||| S:1204 E:1209 ||| NNP
composites  ||| S:1209 E:1220 ||| VBD
significantly  ||| S:1220 E:1234 ||| RB
improved  ||| S:1234 E:1243 ||| VBN
osteoblast  ||| S:1243 E:1254 ||| JJ
mineralization ||| S:1254 E:1268 ||| NN
.  ||| S:1268 E:1270 ||| .
As  ||| S:1270 E:1273 ||| RB
to  ||| S:1273 E:1276 ||| TO
the  ||| S:1276 E:1280 ||| DT
mechanism ||| S:1280 E:1289 ||| NN
,  ||| S:1289 E:1291 ||| ,
treatment  ||| S:1291 E:1301 ||| NN
with  ||| S:1301 E:1306 ||| IN
PPTE  ||| S:1306 E:1311 ||| NNP
composites  ||| S:1311 E:1322 ||| FW
induced  ||| S:1322 E:1330 ||| FW
osteopontin  ||| S:1330 E:1342 ||| FW
( ||| S:1342 E:1343 ||| -LRB-
OPN ||| S:1343 E:1346 ||| NNP
)  ||| S:1346 E:1348 ||| -RRB-
mRNA  ||| S:1348 E:1353 ||| JJ
and  ||| S:1353 E:1357 ||| CC
protein  ||| S:1357 E:1365 ||| NN
expression  ||| S:1365 E:1376 ||| NN
and  ||| S:1376 E:1380 ||| CC
alkaline  ||| S:1380 E:1389 ||| JJ
phosphatase  ||| S:1389 E:1401 ||| JJ
activity ||| S:1401 E:1409 ||| NN
.  ||| S:1409 E:1411 ||| .
Taken  ||| S:1411 E:1417 ||| VBN
together ||| S:1417 E:1425 ||| RB
,  ||| S:1425 E:1427 ||| ,
this  ||| S:1427 E:1432 ||| DT
study  ||| S:1432 E:1438 ||| NN
showed  ||| S:1438 E:1445 ||| VBD
that  ||| S:1445 E:1450 ||| IN
PPTE  ||| S:1450 E:1455 ||| NNP
composites  ||| S:1455 E:1466 ||| NNS
with  ||| S:1466 E:1471 ||| IN
porous  ||| S:1471 E:1478 ||| NN
and  ||| S:1478 E:1482 ||| CC
hydrophilic  ||| S:1482 E:1494 ||| JJ
surfaces  ||| S:1494 E:1503 ||| NN
can  ||| S:1503 E:1507 ||| MD
stimulate  ||| S:1507 E:1517 ||| VB
osteoblast  ||| S:1517 E:1528 ||| JJ
adhesion ||| S:1528 E:1536 ||| NN
,  ||| S:1536 E:1538 ||| ,
proliferation ||| S:1538 E:1551 ||| NN
,  ||| S:1551 E:1553 ||| ,
and  ||| S:1553 E:1557 ||| CC
maturation  ||| S:1557 E:1568 ||| NN
through  ||| S:1568 E:1576 ||| IN
an  ||| S:1576 E:1579 ||| DT
OPN-dependent  ||| S:1579 E:1593 ||| JJ
mechanism ||| S:1593 E:1602 ||| NN
.  ||| S:1602 E:1604 ||| .
Therefore ||| S:1604 E:1613 ||| RB
,  ||| S:1613 E:1615 ||| ,
the  ||| S:1615 E:1619 ||| DT
de  ||| S:1619 E:1622 ||| FW
novo  ||| S:1622 E:1627 ||| FW
PPTE  ||| S:1627 E:1632 ||| FW
scaffolds  ||| S:1632 E:1642 ||| FW
may  ||| S:1642 E:1646 ||| MD
have  ||| S:1646 E:1651 ||| VB
biomaterial  ||| S:1651 E:1663 ||| JJ
potential  ||| S:1663 E:1673 ||| NN
for  ||| S:1673 E:1677 ||| IN
bone  ||| S:1677 E:1682 ||| NN
regeneration ||| S:1682 E:1694 ||| NN
.  ||| S:1694 E:1696 ||| .
